sars-cov-2

Documents about sars-cov-2

• Spatio-temporal transmissibility and dispersion of SARS-CoV-2 variants and sub-variants of concern in England#10217bioRxiv / medRxiv
• Intensivkapazitäten und COVID-19-Intensivbettenbelegung in Deutschland#26343DataCite
• 7-Tage-Inzidenz der COVID-19-Fälle in Deutschland#120831DataCite
• Study of Ameliorating Effect of COVID-19 mRNA Vaccine in Individuals Immunized With Inactivated Vaccine#136409ClinicalTrials.gov
• A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults#158020ClinicalTrials.gov
• B-pVAC-SARS-CoV-2: Study to Prevent COVID-19 Infection in Adults With Bcell/ Antibody Deficiency#160180ClinicalTrials.gov
• Unveiling post-vaccination proteomic signatures in SARS-CoV-2 infection-naïve individuals associated with Omicron breakthrough infections.#174572NCBI PubMed Central
• Length of SARS-CoV-2 shedding in HCT recipients: an Infectious Disease Working Party of EBMT study#231808IRIS
• In silico design and validation of high-affinity RNA aptamers for SARS-CoV-2 comparable to neutralizing antibodies#245293bioRxiv / medRxiv
• Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19#279580ClinicalTrials.gov
• Targeting SARS-CoV-2 Non-Structural Proteins: A Blueprint for Next-Generation Small-Molecule Coronavirus Antivirals.#319129NCBI PubMed Central
• The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets#319337PubMed Central
• An Update on Anti-COVID-19 Vaccines and the Challenges to Protect Against New SARS-CoV-2 Variants#326299HAL (France)
• SARS-CoV-2 reinfection: a possible contributing factor to long COVID in children and adolescents.#330937NCBI PubMed Central
• SAFETY, EFFICACY, AND IMMUNOGENICITY OF SARS-COV-2 MRNA VACCINES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS#334543ScholarBank@NUS
• Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19)#343701ClinicalTrials.gov
• Does infection with Leishmania protect against Covid-19?#357579HAL (France)
• Ephedrae Herba as a potential source of SARS-CoV-2 RNA-dependent RNA polymerase inhibitory activity.#378451NCBI PubMed Central
• Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults#417575ClinicalTrials.gov
• Characteristics Influencing Adherence to SARS-CoV-2 Serial Antigen Testing Following a Federal Safety Communication: Cohort Study.#418489NCBI PubMed Central
• Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults#432940ClinicalTrials.gov
• RAAS antagonists dampen the SARS-CoV-2 infection in ex-vivo cultured human precision-cut lung slices#449082JLUpub
• Germline based SARS-CoV-2 specific B cell repertoire motif identified with novel sequence based bioinformatic pipeline.#472529NCBI PubMed Central
• Immune correlates of risk for SARS-CoV-2 infection in children: a prospective, community-based cohort study.#479296NCBI PubMed Central
• Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells#665041Enlighten Publications
• Global analysis of protein-RNA interactions in SARS-CoV-2 infected cells reveals key regulators of infection#665042Enlighten Publications
• Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccine#666864Repositorio Universidad del Desarrollo
• Ethics as if Your Life Depended on It.#679685PubMed
• Protein Electrophoresis as a Tool for Complications Prediction in COVID-19 Hospitalised Patients#811859ClinicalTrials.gov
• Clinical Evaluation of the VitaSIRO Solo™ Respiratory Assay#829637ClinicalTrials.gov
• Seroprevalence of SARS-Cov-2 Antibodies in Children#835980ClinicalTrials.gov
• Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection#842996ClinicalTrials.gov
• WORLD HEART FEDERATION (WHF) COVID-19 and Cardiovascular Disease Survey#851531ClinicalTrials.gov
• Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2#873426ClinicalTrials.gov
• Immunomodulatory Effect of Probiotics on the Immunogenicity of Anti-SARS-CoV-2 Vaccines#873439ClinicalTrials.gov
• National Survey Concerning Vaccination Against COVID-19 in Nursing Homes and Long-Term Care Units#875175ClinicalTrials.gov
• Clinical Study of Pregnant Women With COVID-19#875967ClinicalTrials.gov
• Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection#878704ClinicalTrials.gov
• Seroepidemiological Investigation of Coronavirus 2019 (COVID-19) Infection in Gabon#880648ClinicalTrials.gov
• Bioluminate, Osprey and Covalent Docking data - Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir#401088Universität Innsbruck
• Blood Collection Study From COVID-19 Convalescents Previously Hospitalized to Identify Immunogenic Viral Epitopes#875824ClinicalTrials.gov
• Identification and genomic characterization of BA.3.2: a highly divergent BA.3-related SARS-CoV-2 lineage from southern Africa.#4472NCBI PubMed Central
• Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients#836695ClinicalTrials.gov
• Abwassersurveillance AMELAG#14681DataCite
• Prenatal exposure to SARS-CoV-2, early relational health, and child socio-emotional functioning in the first 6 months#18867bioRxiv / medRxiv
• Unraveling the Mechanism of Drug Binding to SARS-CoV-2 RNA Pseudoknot with Thermodynamics-Driven Machine Learning#19037arXiv CS
• Abwassersurveillance AMELAG#124857DataCite
• Genomic Characterization and Evolutionary Dynamics of SARS-CoV-2 Lineage NB.1.8.1 in Thailand, 2025.#140903NCBI PubMed Central
• Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age#143662ClinicalTrials.gov
• Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia#148551ClinicalTrials.gov